Board of Directors

Joseph A. Trunfio, Ph.D.

Dr. Trunfio is former President and Chief Executive Officer of Atlantic Health System, one of the largest non-profit health care systems in New Jersey and consistently ranked among the best health care systems in the nation. Dr. Trunfio is a member of the boards of directors of Cross Country, Inc., New Jersey Hospital Association, QualCare, Inc., QualCare Alliance Networks, Inc., Fair Share Hospitals Collaborative, McKesson Technology Solutions Advisory Board, and the New Jersey Council of Teaching Hospitals. Dr. Trunfio holds an M.S. and a doctorate degree in clinical psychology from the University of Miami in Florida and has completed post-doctoral fellowships at Albert Einstein College of Medicine in New York City and the National Institute of Mental Health in Rockville, Maryland. He completed his undergraduate work in psychology at St. John’s University in Queens, New York.

F. Nicholas Jacobs, FACHE - Founder of CTGRI

F. Nicholas (Nick) Jacobs is a Fellow in the American College of Health Care Executives and serves as the international director and a partner in SunStone Management Resources, LLC, a firm that assists health care providers throughout the U.S. establish integrative and genetic medicine programs. Previously he served as CEO and President of Windber Medical Center and the co-founder of the Windber Research Institute (now the Chan Soon-Shiong Institute of Molecular Medicine), a translational proteomic and genomic research center for breast cancer, female reproductive, and heart diseases affiliated with the Walter Reed National Military Medical Center in Bethesda, Maryland. He is also co-founder of the Clinical Breast Care Project for the Department of Defense. Mr. Jacobs holds a master’s degree in public management and health systems management from Carnegie Mellon University, master's and bachelor's degrees in education from Indiana University of Pennsylvania, and a certification in health systems management from Harvard University

Robert Gasparini, M.S., M.S., CLSp(CG), CLDir

Mr. Gasparini is the co-founder and former president and Chief Scientific Officer of NeoGenomics Laboratories, Inc., a publicly-traded cancer genetics diagnostics company. He helped build NeoGenomics across six locations in the U.S. including senior management, laboratories, HR, IT, sales, marketing, finance, compliance, research and development, and customer care. He developed the first U.S. genetic technology education program at the University of Connecticut. He also helped develop the national certification examination (NCA) for genetic technologists and the national accreditation process (NAACLS) for genetics programs. He has published 15 peer-reviewed articles, over 30 published peer-reviewed abstracts, and has given over 250 invited presentations. He has over 28 years of combined service on national committees and Boards of Directors. He holds 14 awards including the Association of Genetic Technologists Lifetime Achievement Award.

Ronald B. Toll, Ph.D.

Ronald B. (Ron) Toll serves as Provost and Vice President for Academic Affairs at Florida Gulf Coast University. Dr. Toll served as Vice President for Academic Affairs and Dean of the Faculty, and full professor of Biology at Lebanon Valley College in Pennsylvania. From 1999 to 2005, he was Dean for the College of Natural Sciences and Mathematics, and Special Assistant to the President for Technology and Corporate Relations from 2003 to 2005 at the University of Central Arkansas. From 1995 to 1999, Dr. Toll held several titles at Wesleyan College including chair in the Division of Natural Sciences and Mathematics and the Department of Biology, and Munroe Professor of Life Sciences (endowed chair). Dr. Toll was associate and assistant professor of Biology at University of the South in Tennessee from 1990 to 1993. He is widely published in professional periodicals and journals. Dr. Toll earned a Ph.D. in Biological Oceanography from the University of Miami in 1982, a Bachelor of Arts in Zoology from Rutgers University in 1977, and an Associate in Arts in Biology from Union College in New Jersey in 1975. In 2004, he earned a graduate certificate from Harvard Institute for Management and Leadership in Education.

Lee Bronfman, R.N.

Ms. Bronfman is a health care executive with over 25 years' experience developing and implementing innovative projects and programs. She previosly served as Administrative Director of the Walter Reed National Military Medical Center, where she provide executive level oversight for the Breast Cancer Translational Research Center of Excellence. During that time, Ms. Bronfman managed the research for the Clinical Breast Care Project, a military-civilian partnership for studying breast cancer and breast disease. She has also served as the Director of Nursing Quality and Management Services at the National Rehabilitation Hospital in Washington, D.C. and Administrative Director and Research Protocol Coordinator of the Henry M. Jackson Foundation. She is a Certified Clinical Research Professional and holds a B.S.N. in Nursing from D’Youville College, Buffalo, New York and an M.A. in Education from George Washington University.

Dan Asimus, M.D., M.A.Ed., ABIHM

Dr. Asimus is Board Certified in Psychiatry, Neurology and is a Diplomate in Integrative Holistic Medicine. He is founder and Medical Director of the Life Fitness Center with offices on Maui, Hawaii, and in Pasadena, California. Dr. Asimus attended Xavier University in Cincinnati, Ohio, and then the University of Cincinnati College of Medicine. He then moved to Los Angeles to complete his medical internship and psychiatric residency at the University of Southern California. He has always loved teaching as well as practicing medicine and obtained a Master’s Degree in Science and Medical Education also at USC.

Chief Scientific Officer

Dan Handley, M.S., Ph.D.

Dr. Handley serves as the Chief Scientific Officer of the Clinical and Translational Genome Research Institute and holds a courtesy faculty appointment in the Department of Biological Sciences at Florida Gulf Coast University. His areas of specialty include drug-gene interactions (pharmacogenomics), microbiome research and metabolomics, computational systems biology, and machine learning. He previously served as the Chief Scientific Officer for Advanced Healthcare Technology Solutions, Inc., as a senior researcher at the Procter & Gamble Co., a senior administrator, researcher, and laboratory manager at the David Geffen UCLA School of Medicine, and as a founding biotechnology inventor for the National Genetics Institute. He holds a B.A. in Biophysics from Johns Hopkins University, an M.S. in Logic and Computation from Carnegie Mellon University, a Ph.D. in Human Genetics from the University of Pittsburgh, and did his post-doctoral training at Magee-Womens Research Institute in advanced genomic technologies applied to fetal and maternal health.



Copyright © 2018. Clinical and Translational Genome Research Institute, Inc., All rights reserved.